含硅磷酸钙骨水泥的理化性质及体外细胞毒性

用共沉淀反应法制备硅酸三钙(C3S),将所制备的硅酸三钙(C3S)加入到磷酸钙系骨水泥(CPC)中,制备了一种新型的硅磷酸钙骨水泥(CPSC).研究了该复合骨水泥的理化性质和体外细胞毒性.与CPC骨水泥相比,硅磷酸钙骨水泥(CPSC)的固化时间延长,添加适量的C3S可提高CPC的抗压强度;在模拟体液(SBF)浸泡设定时间后,硅磷酸钙骨水泥(CPSC)降解率增加,并且在浸泡初期,SBF的pH增加.体外细胞毒性实验结果显示:复合C3S骨水泥浸提液能促进成纤维细胞的增殖,表明硅磷酸钙骨水泥有良好的生物相容性.含C3S的磷酸钙骨水泥可作为骨组织再生的生物材料使用.     

钙磷物质的量比对磷酸钙骨水泥性能的影响

本研究通过在磷酸钙骨水泥(calcium phosphate cement,CPC)固相配方中添加不同量的氯化钙(CaCl2),制备不同钙磷物质的量比的CPC,研究不同钙磷物质的量比对CPC性能的影响。测试CPC的初、终凝时间。将CPC体外模拟浸泡3d和7d,研究模拟生理条件下CPC的性能,分别利用X-射线衍射(XRD)、力学性能实验机、扫描电镜(SEM)等研究CPC相成分、抗压强度和断面微观形貌。通过化学滴定测定浸泡液中氯离子浓度。结果表明:提高钙磷物质的量比不会显著延长CPC凝结时间;模拟浸泡液中的氯离子浓度处于正常生理条件的范围内;随钙磷物质的量比的增加,水化后CPC的抗压强度显著提高,而经过体外模拟浸泡后,钙磷物质的量比为1.67和1.80的CPC的抗压强度明显下降;具有较高钙磷物质的量比的CPC体外模拟浸泡后,形成多孔结构、弱结晶类骨磷灰石的终产物。     

磷酸钙骨水泥/聚肽共聚物生物复合材料力学性能及微观结构

磷酸钙骨水(Calcium Phosphate Cement,CPC)是一种新型的人工骨材料,可用于人体骨缺损的修复,具有良好的生物相容性、骨传导性和骨替代性．然而,磷酸钙骨水泥的抗压强度较低,脆性较大,限制了其应用,因而提高抗压强度和减小其脆性成为CPC研究领域的一个重要课题．目前,普遍采用添加纤维的方法来提高CPC材料的抗压强度和韧性．然而大多数的纤维是非降解性的．     

氧化钛催化羟基磷灰石分解制备可降解磷酸钙陶瓷

本文将纳米锐钛矿型氧化钛(TiO2)作为催化剂添加到羟基磷灰石(HA)中,经烧结制成可降解的磷酸钙陶瓷,采用X射线衍射(XRD),扫描电镜(SEM),体外模拟实验等手段对不同制作工艺的陶瓷进行表征,考察TiO2的添加量和保温时间对磷酸钙陶瓷性能的影响。实验表明,在较低的温度下,TiO2可以降低HA的高温稳定性,使HA分解成磷酸四钙(TTCP)和磷酸三钙(TCP)。由于TCP具有良好的降解性,TiO2的加入极大的提高了HA的降解速率,且随着TiO2添加量的增加降解速率逐渐增大,保温时间越长,降解速率愈小;浸泡SBF结果显示,TiO2的加入可以提高陶瓷沉积活性磷灰石层的能力,但沉积能力与TiO2添加比例不成正比,添加7wt%的材料沉积最快;细胞实验表明,TiO2的加入不影响HA促进细胞增殖分化的能力。使用氧化钛催化分解HA,可能是制备具有良好生物学性能的可降解磷酸钙陶瓷的有效手段。     

三维打印双固化POXC/CPC可降解骨修复支架

从成分设计和结构控制着手,在木糖醇部分取代1,8-辛二醇与柠檬酸聚合反应制备聚(柠檬酸-辛二醇-木糖醇)酯(POXC)的基础上,采用POXC预聚体与磷酸钙骨水泥(CPC)悬浮体三维打印了孔道贯通的POXC/CPC多孔复合预支架,并进一步采用固化反应制备得到该复合支架。探索了材料的可打印参数,评价了复合支架的降解性、润湿性以及生物相容性。结果表明,POXC的降解速率随着木糖醇取代度的增加而增大。56d后,POXC/CPC降解率高达43%,对照组聚(1,8-辛二醇-柠檬酸)酯/CPC(POC/CPC)降解率近10%,这是由于POXC与复合支架的贯通孔结构的协同作用所致。木糖醇的引入及其与CPC的复合大大提高了支架的亲水性,有利于细胞的黏附和增殖。POXC/CPC支架具有贯通的大孔结构、良好的生物相容性和降解性,可促进骨缺损的修复。     

非化学计量羟基磷灰石骨水泥的制备及性能研究

采用磷酸四钙和磷酸氢钙混合粉末制备了nCa/nP比为1.58的非化学计量羟基磷灰石骨水泥(n-HAC)及其多孔支架材料。结果表明:与nCa/nP=1.67的化学计量羟基磷灰石骨水泥(HAC)相比,n-HAC的凝结时间和抗压强度没有明显的区别。XRD和IR显示:n-HAC与HAC都为羟基磷灰石结构,但n-HAC在Tris-HCl缓冲溶液的降解性明显大于HAC。细胞培养结果表明:成骨细胞在n-HAC和HAC两种材料上的粘附和细胞形态没有明显的区别,但细胞在n-HAC上的增殖率明显高于HAC。将多孔n-HAC支架材料植入兔股骨缺损处,观察其修复骨缺损情况,组织学分析结果表明:新生骨在多孔支架的表面形成,并长入其内部;n-HAC在体内的降解比HAC快,能明显地促进新骨生成。     

新型介孔羟基磷灰石/壳聚糖-万古霉素药物释放系统复合材料的制备及体外抗菌和成骨能力

采用冷冻干燥法合成了介孔羟基磷灰石(HA)/壳聚糖(CS)-万古霉素(VCM)药物释放系统复合材料, 利用SEM, XRD和FTIR等方法对材料进行了表征. 结果证实CS与HA混合复合材料具有良好的孔径和孔隙率, 万古霉素吸附于复合材料的表面和内部. 细胞毒性实验[噻唑蓝(MTT)比色法]结果表明, 材料可以促进成骨细胞增殖且具有良好的细胞相容性. 体外抑菌实验结果证实此材料可长时间抑制耐甲氧西林金葡菌(MRSA)的生长, 具有良好的抑菌和杀菌能力. 细胞黏附实验结果表明, 成骨细胞附着于材料表面增殖并通过孔道延伸. 实时聚合酶链式反应(RT-PCR)实验结果表明, 在成骨相关标志产物胶原蛋白-1(COL-1)及骨形态发生蛋白-2(BMP-2)基因上均有较高的表达, 表明材料在体外可以促进成骨细胞生长, 具有良好的成骨能力.     

载药脂质体复合缺钙磷灰石骨水泥支架的研究

采用食盐颗粒浸出法制备了缺钙磷灰石水泥(CPC)多孔支架;用脂质体包裹盐酸万古霉素制备了载药脂质体。将它们两者结合,制备了脂质体载药复合缺钙磷灰石水泥(dl-CPC)支架。结果表明:缺钙CPC多孔支架能够将载药脂质体吸附在其大孔表面或微孔里;dl-CPC支架对MC3T3-E1细胞的生长没有负面影响,显示出良好的细胞相容性。此外,dl-CPC支架具有很好的抗菌性能,能够抑制大肠杆菌生长,抗菌率达99%(12 h)。dl-CPC支架浸泡在磷酸缓冲溶液中,释放药物的速度比较缓慢(前4周);而直接吸附药物的CPC支架,在1周内大部分药物释放出来,出现暴释现象。另结果表明:dl-CPC支架具有缓释药物和骨再生的双重功能,可用于骨缺损的修复及治疗慢性骨髓炎。     

多巴胺对磷酸钙骨水泥性能影响的研究

本论文研究含儿茶酚的多巴胺对磷酸钙骨水泥(calcium phosphate cement,CPC)的理化性能和体外降解的影响。将多巴胺溶于Tris-HCl缓冲液于空气中氧化2 d,作为液相与固相粉末混合成型。选取多巴胺浓度、液固比、pH值三因素,通过正交试验选取最优组合。采用万能力学试验机、吉尔摩(Gilmore)针、X射线衍射仪(XRD)、傅立叶红外光谱仪(FTIR)表征含多巴胺CPC的理化性能,用扫描电镜(SEM)观察微观形貌、用紫外可见光分光光度计研究含多巴胺CPC的体外降解。抗压强度结果表明最优组为多巴胺浓度40 mg.mL-1、液固比0.3 mL.g-1、pH值8.5,最优组CPC抗压强度最高,与空白CPC相比具有极显著性差异(p<0.01);最优组CPC凝结时间与空白组比较无显著性差异且符合临床要求;XRD和FTIR结果表明多巴胺的加入促进了二水磷酸氢钙(DCPD)的转化;SEM观察发现多巴胺的加入使CPC内部形成了片状结构及较多紧密结合的块状晶体且与空白CPC相比孔隙明显减少;最优组CPC体外降解过程中,多巴胺的累积释放量为加入总量的29.7%,且浸泡过程中浸泡液的pH变化处于人体安全范围内。     

生物降解高分子/羟基磷灰石复合材料研究进展

由于高分子/HA复合材料兼具HA优良的生物性能和高分子材料良好的力学性能而受到了广泛的重视.本文综述了近年来生物降解高分子/羟基磷灰石复合材料的研究进展,介绍了胶原及其衍生物、聚酯、甲壳素及其衍生物、淀粉等可降解高分子材料与羟基磷灰石复合作为骨修复材料的研究进展,并对此类材料存在的问题和发展前景进行了讨论.     

On the existence of bivalent ions in the apatite channels: A new example—Phosphocalcium cyanamido-apatite

A new apatite, phosphocalcium cyanamido-apatite Ca₁₀(PO₄)₆ CN₂ □, is obtained by treatment under low pressure at high temperature (900–1000°C) of a mixture of the corresponding hydroxyapatite and calcium cyanamide. In this apatite, one CN^2?₂ ion associated with a vacancy replaces two hydroxyl ions in the channels. The formation of a cyanamide-containing apatite also occurs by treatment of an A-type carbonated apatite by ammonia at 600–900°C: in the latter case, the reaction seems more difficult and more limited than in the former. The cyanamido apatite is decomposed by heating in air, and it gives rise first to an A-type carbonated apatite, with release of both ammonia and nitrogen oxide and second to hydroxyapatite by hydrolysis of the A-type carbonated apatite.     

与胶原特异性结合的BMP2模拟肽/PLGA 3D打印复合支架的制备及成骨诱导活性

将胶原绑定结构域(CBD)多肽序列与骨形态发生蛋白2模拟肽(BMP2-MP)序列连接制备具有胶原绑定能力的CBD-BMP2-MP, 再将CBD-BMP2-MP与聚丙交酯-乙交酯/胶原(PLGA/COL)3D打印支架相结合, 以支架表面的胶原成分为媒介, 将CBD-BMP2-MP更有效地固定于骨修复材料上, 达到对其进行改性的目的. 利用扫描电子显微镜(SEM)、 电子万能试验机和接触角测量仪对复合支架表面形貌、 力学强度和亲水性等材料学性能进行评价. 用荧光成像法评测 CBD-BMP2-MP及BMP2-MP与支架材料的结合能力. 在各组支架材料表面接种MC3T3-E1细胞进行体外培养, 采用CCK-8、 鬼笔环肽荧光染色、 茜素红染色及qPCR综合评价细胞在材料表面的黏附、 增殖和成骨分化等细胞行为, 研究CBD-BMP2-MP修饰的3D多孔PLGA/COL复合支架的生物学性能. 研究结果表明, 利用3D打印技术制备的多孔支架具有形貌可控的孔隙结构, 为细胞生长创造更有利的细胞微环境, 支架表面胶原成分的加入提高了支架材料的亲水性, 同时对支架材料本身的力学性能无任何影响, 提高了复合支架本身的生物相容性. 与普通BMP2-MP相比, CBD-BMP2-MP具有更好的胶原绑定能力, 与复合支架的结合更稳定, 提高了PLGA/COL复合支架对BMP2-MP的负载能力. 支架表面负载CBD-BMP2-MP后具有极强的促细胞成骨分化能力. MC3T3-E1细胞表现出更高的钙沉积能力, 并且成骨分化相关基因Runx2, ALP, COL-I及OPN等水平也有了明显提升. 表明CBD-BMP2-MP多孔复合支架具有良好的生物相容性和成骨诱导活性, 在骨组织修复领域具有良好的应用前景.     

Evaluation of a novel nanocrystalline hydroxyapatite powder and a solid hydroxyapatite/Chitosan-Gelatin bioceramic for scaffold preparation used as a bone substitute material

Artificially fabricated hydroxyapatite (HAP) shows excellent biocompatibility with various kinds of cells and tissues which makes it an ideal candidate for a bone substitute material. In this study, hydroxyapatite nanoparticles have been prepared by using the wet chemical precipitation method using calcium nitrate tetra-hydrate [Ca(NO₃)₂.4H₂O] and di-ammonium hydrogen phosphate [(NH₄)₂ HPO₄] as precursors. The composite scaffolds have been prepared by a freeze-drying method with hydroxyapatite, chitosan, and gelatin which form a 3D network of interconnected pores. Glutaraldehyde solution has been used in the scaffolds to crosslink the amino groups (|NH₂) of gelatin with the aldehyde groups (|CHO) of chitosan. The X-ray diffraction (XRD) performed on different scaffolds indicates that the incorporation of a certain amount of hydroxyapatite has no influence on the chitosan/gelatin network and at the same time, the organic matrix does not affect the crystallinity of hydroxyapatite. Transmission electron microscope (TEM) images show the needle-like crystal structure of hydroxyapatite nanoparticle. Scanning Electron Microscope (SEM) analysis shows an interconnected porous network in the scaffold where HAP nanoparticles are found to be dispersed in the biopolymer matrix. Fourier transforms infrared spectroscopy (FTIR) confirms the presence of hydroxyl group (OH^-) , phosphate group (PO^3-₄) , carbonate group (CO^2-₃) , imine group (C=N), etc. TGA reveals the thermal stability of the scaffolds. The cytotoxicity of the scaffolds is examined qualitatively by VERO (animal cell) cell and quantitatively by MTTassay. The MTT-assay suggests keeping the weight percentage of glutaraldehyde solution lower than 0.2%. The result found from this study demonstrated that a proper bone replacing scaffold can be made up by controlling the amount of hydroxyapatite, gelatin, and chitosan which will be biocompatible, biodegradable, and biofriendly for any living organism.     

Preparation and Characterization of Polyhydroxyalkanoates Macroporous Scaffold Through Enzyme-Mediated Modifications

Polyhydroxyalkanoates (PHAs) are hydrophobic biodegradable thermoplastics that have received considerable attention in biomedical applications due to their biocompatibility, mechanical properties, and biodegradability. In this study, the degradation rate was regulated by optimizing the interaction of parameters that influence the enzymatic degradation of P(3HB) film using response surface methodology (RSM). The RSM model was experimentally validated yielding a maximum 21 % weight loss, which represents onefold increment in percentage weight loss in comparison with the conventional method. By using the optimized condition, the enzymatic degradation by an extracellular PHA depolymerase from Acidovorax sp. DP5 was studied at 37 °C and pH 9.0 on different types of PHA films with various monomer compositions. Surface modification of scaffold was employed using enzymatic technique to create highly porous scaffold with a large surface to volume ratio, which makes them attractive as potential tissue scaffold in biomedical field. Scanning electron microscopy revealed that the surface of salt-leached films was more porous compared with the solvent-cast films, and hence, increased the degradation rate of salt-leached films. Apparently, enzymatic degradation behaviors of PHA films were determined by several factors such as monomer composition, crystallinity, molecular weight, porosity, and roughness of the surface. The hydrophilicity and water uptake of degraded salt-leached film of P(3HB-co-70%4HB) were enhanced by incorporating chitosan or alginate. Salt-leached technique followed by partial enzymatic degradation would enhance the cell attachment and suitable for biomedical as a scaffold.     

The structure and solubility of carbonated hydroxyl and chloro lead apatites

The properties of carbonated hydroxyl and chloro lead apatites, Pb₁₀(PO₄)₆(OH)₂ and Pb₁₀(PO₄)₆Cl₂, serve as models for the incorporation of carbonate into their medically important calcium analogs, and there is likely incorporation of carbonate in an insoluble lead phosphate phase during lead remediation. We have synthesized a series of carbonated lead hydroxyl- and lead chloro-apatites at 60–80 °C. The incorporation of carbonate into the apatite structure was documented by X-ray powder diffraction, IR and Raman spectroscopy, ²⁰⁷Pb solid state NMR spectroscopy, and elemental analysis. The carbonate content was determined by combustion analysis and confirmed by Raman spectroscopic analysis. As carbonate content increases in hydroxyl lead apatite, Raman spectra show changes in the phosphate stretching modes at 925 and 950 cm⁻¹, an increase in intensity and downshift of a new peak at 1050 cm⁻¹, and changes in the spectral features of the O–H stretch at about 3560 cm⁻¹. The variation in unit cell parameters for the chloro lead apatite as a function of carbonate content is similar to that documented for B-type substitution in calcium apatites. The ²⁰⁷Pb NMR spectra corroborate B-type substitution. For the hydroxyl lead apatite, the changes in cell parameters suggest a combination of A- and B-type substitution. Solubilities of the carbonated lead apatites, determined by ICP-MS, increase slightly at low to moderate carbonate content, but more strongly at ca. 5.0 wt.% carbonate content. K_sp values extrapolated to zero carbonate content reveal that the chloro lead apatite is indeed less soluble than the hydroxyl analog.     

Effect of starch content on the biodegradation of polycaprolactone/starch composite for fabricating in situ pore-forming scaffolds

Bone tissue engineering is an efficient approach to regenerating bone-related defects. The optimal scaffold used for bone tissue engineering must possess adequate porosity and suitable mechanical properties. This work described the development of a biodegradable polymeric composite based on polycaprolactone (PCL) and starch that can form a porous structure in situ. The scaffold exhibited the required mechanical properties at the initial stage of implantation by controlling in situ degradation and subsequent pore formation. PCL/starch (SPCL) scaffolds with 100/0, 70/30, and 50/50 ratios were developed. Degradation studies were performed in phosphate buffer saline (PBS) containing α-amylase or lipase at 37 °C for 4 weeks. Fourier-transform infrared spectroscopy was used to analyze chemical bonds and their changes after degradation. Differential scanning calorimetry was applied to determine the crystallinity and recrystallization of samples before and after degradation. Mass loss and starch release were observed during degradation, and the porosity of samples was measured by the ethanol replacement method. Morphology was further determined using scanning electron microscopy. Finally, variations in compressive strength and modulus during degradation and pore formation were also measured. The porosity of samples reached 45% after 1 month of degradation, and mechanical properties were still appropriate for human bone tissue. Reduction in mechanical property after mass loss, starch release and pore formation was controlled by the hydrogen bonding and recrystallization effect of PCL after degradation. Results suggested that SPCL composite had potential to form porous scaffold with adequate mechanical properties in situ and is promising for bone tissue engineering applications.     

A Novel Resorbable Composite Material Containing Poly(ester-co-urethane) and Precipitated Calcium Carbonate Spherulites for Bone Augmentation—Development and Preclinical Pilot Trials

Polyurethanes have the potential to impart cell-relevant properties like excellent biocompatibility, high and interconnecting porosity and controlled degradability into biomaterials in a relatively simple way. In this context, a biodegradable composite material made of an isocyanate-terminated co-oligoester prepolymer and precipitated calcium carbonated spherulites (up to 60% w/w) was synthesized and investigated with regard to an application as bone substitute in dental and orthodontic application. After foaming the composite material, a predominantly interconnecting porous structure is obtained, which can be easily machined. The compressive strength of the foamed composites increases with raising calcium carbonate content and decreasing calcium carbonate particle size. When stored in an aqueous medium, there is a decrease in pressure stability of the composite, but this decrease is smaller the higher the proportion of the calcium carbonate component is. In vitro cytocompatibility studies of the foamed composites on MC3T3-E1 pre-osteoblasts revealed an excellent cytocompatibility. The in vitro degradation behaviour of foamed composite is characterised by a continuous loss of mass, which is slower with higher calcium carbonate contents. In a first pre-clinical pilot trial the foamed composite bone substitute material (fcm) was successfully evaluated in a model of vertical augmentation in an established animal model on the calvaria and on the lateral mandible of pigs.     

丝素蛋白修饰改性的聚羟基脂肪酸酯支架上人体平滑肌细胞的生长

聚三羟基丁酸脂和聚三羟基己酸脂的共聚物(PHBHH_x)是一种具有良好强度和韧性的生物可降解高分子材料, 可作为组织工程心脏瓣膜支架的选择材料之一. 但其生物相容性尚不甚理想. 为此, 本工作利用丝素蛋白修饰改性高分子多孔支架, 以提高支架的生物相容性. 并将人体平滑肌细胞接种在该复合支架上进行体外培养, 以证实改性效果. 其中, 用3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐(MTT)方法测试细胞生长, 评估复合支架的细胞相容性. 并用扫描电子显微镜观察细胞在支架上的生长形态. 结果显示, 丝素蛋白修饰改性后的复合支架更有利于细胞的粘附与生长, 平滑肌细胞在支架上表现出良好的生长形态. 这表明, 丝素能够改善多孔支架的生物相容性, 使PHBHH_x/丝素蛋白复合物能更适宜作为组织工程心脏瓣膜的支架材料. 结果对于进一步研究细胞外间质在复合支架上的生长以及体外培养的组织重建有重要的参考意义.